@SondosZayedMD Profile picture

Sondos Zayed

@SondosZayedMD

MD | Radiation Oncologist | The Ottawa Hospital | #WomenWhoCurie | Public Health & Gender Equity advocate | Tweets = Own views | 2023 #WXNTop100

Similar User
Alex Louie MD, PhD photo

@DrAlexLouie

Elaine M. Zeman, PhD photo

@DrZeman

@jessschuster photo

@jessschuster1

Mark Corkum MD, MSc, FRCPC, DRCPSC photo

@DrMarkCorkum

Rohann Correa photo

@DrCorreaRO

Mark V. Mishra photo

@MarkMishraMD

Emily Daugherty, MD photo

@NerdicasMaximus

Kiran Devisetty, MD, FASTRO photo

@KiranDevisetty

Tris Arscott, MD photo

@wtarscott

Rachel Glicksman photo

@r_glicksman

Christian Fernandez Olortegui photo

@ChrisFernOlor

Chris Goodman photo

@goodmanC_MD

Aparna Kesarwala photo

@AKesarwala

Zain Siddiqui photo

@ZainSiddiquiMD

Nitika Paudel, MD.PhD photo

@NitikaPaudel

Sondos Zayed Reposted

December 1 2024 podcast on a hot topic Irradiating Polymetastatic Disease -- with Mai Anh Huynh @BrighamRadOnc @drdavidpalma @ebludmir Direct link (right click to download for no cache/skips): redjournal.org/pb-assets/Heal…

Tweet Image 1
Tweet Image 2

Sondos Zayed Reposted

Hey Rad Onc residents, check this out ⬇️⬇️⬇️ @ARRO_org @caroresidents @ESTRO_RT

Calling all radiation oncology residents – we’re looking for volunteers to test out new neuroanatomy modules for the ARC Bootcamp! Please email us at neuroarcstudy@gmail.com if interested!

Tweet Image 1


Sondos Zayed Reposted

Sharing our NRG pancreas contouring atlas - now in press! Target volume delineation for dose-escalated RT in pancreas cancer has been highly variable, making it difficult to rigorously assess the efficacy and toxicity of RT. redjournal.org/article/S0360-… 1/13


Sondos Zayed Reposted

Great piece on history of medical journals & absurdity of publishing industry complex. “a unique & bizarre ecosystem; the ppl who provide both content & external peer review receive no payment from the publisher, who generates revenue from the content.” link.springer.com/article/10.100…


Sondos Zayed Reposted

#SBRT for liver metastases: Systematic review and meta-analysis with International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines #radonc practicalradonc.org/article/S1879-…

Tweet Image 1

Sondos Zayed Reposted

This intrahepatic cholangiocarcinoma review focuses on future and current strategies, including an algorithm that can be used to drive a personalized and multidisciplinary approach for patients w/ this malignancy. @michael_lidsky @DimitriosMoris Read at: acsjournals.onlinelibrary.wiley.com/doi/full/10.33…

Tweet Image 1

Sondos Zayed Reposted

Excited to share about NRG GI-011 (aka LAP100) – anticipated opening in mid/early 2025. In this Phase III RCT, we are assessing the benefit of dose-escalated radiotherapy in patients with locally advanced unresectable pancreas cancer. 🧵1/11

Tweet Image 1

Sondos Zayed Reposted

This new #RedJournal article from Tan et al was presented recently at #ASTRO24 during the Scientific Session 32. Read their article on measuring the integration of stereotactic ablative radiotherapy plus surgery for early-stage NSCLC here: tinyurl.com/tanam24

Tweet Image 1

Sondos Zayed Reposted

We ❤️ @ASTRO_org! Thanks to everyone for yet another annual conference in the books! We had so much fun at #ASTRO24 and at the debut of our #minimicinterviews! Here is @drviviantan discussing the outcomes of the MISSILE early-stage lung trial!


Sondos Zayed Reposted

Presented 🚀 MISSILE 🚀 at #ASTRO2024 Combined ☢️ #SABR and 🔪 #surgery in early 🫁 #NSCLC was safe with reasonable clinical outcomes, but similar to surgery alone 🚨 Publication in RED journal here authors.elsevier.com/sd/article/S03… @drdavidpalma @DrAlexLouie @DrCorreaRO @TimkWin

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Sondos Zayed Reposted

Here are the long-term outcomes from MISSILE, presented by @drviviantan with concurrent publication in @IJROBP When we started, we were hopeful for an additive or immunologic effect. We didn't find that, but the approach is safe & can be useful in some contexts, like SABR-BRIDGE

Presented 🚀 MISSILE 🚀 at #ASTRO2024 Combined ☢️ #SABR and 🔪 #surgery in early 🫁 #NSCLC was safe with reasonable clinical outcomes, but similar to surgery alone 🚨 Publication in RED journal here authors.elsevier.com/sd/article/S03… @drdavidpalma @DrAlexLouie @DrCorreaRO @TimkWin

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4


Sondos Zayed Reposted

Which guidelines have radiation for HCC? @ldawsonmd explains at the first joint JASTRO @ASTRO_org joint education session! #SBRT

Tweet Image 1
Tweet Image 2
Tweet Image 3

Sondos Zayed Reposted

👤 NRG-HN005 presented during plenary at #ASTRO2024 #radonc @sueyom 1️⃣ Arm 1: 70 Gy + cisplatin - PFS 98.1% 2️⃣ Arm 2: 60 Gy + cisplatin - PFS 88.6% 3️⃣ Arm 3: 60 Gy + nivolamab - PFS 90.3% ➡️ SOC remains 70 Gy + cisplatin

Tweet Image 1
Tweet Image 2

Sondos Zayed Reposted

Finally headed to DC for #ASTRO24. If you're staying til Weds, I will be presenting our NRG consensus contouring atlas for pancreas SBRT. Please join! Room 144, 11:10 AM

Tweet Image 1
Tweet Image 2

Sondos Zayed Reposted

Here are the daily pain scores from OPTIMAL - higher scores are worse, light blue is the opioid arm. Superior pain control over the full follow-up period with MMA. We think the scores diverge when the pregabalin gets titrated up.

Tweet Image 1

Sondos Zayed Reposted

@SondosZayedMD presenting OPTIMAL at #ASTRO2024 Opioid vs MMA in H&N #cancer 👤 💡 mean pain score during last 7 days RT Opioid 5.10 vs MMA 4.85 (non-inferiority p=0.039, superiority p=0.724) @drdavidpalma @pencilla @DrCorreaRO @goodmanC_MD

Tweet Image 1
Tweet Image 2

Grateful for the opportunity to present OPTIMAL #ASTRO2024 - our pragmatic RCT: #MMA vs opioids for mucositis pain in #HNC 👉#MMA non inf to opioid analgesia last wk of ☢️ and superior for pain relief up to 6 weeks post ☢️ A huge merci to my mentor @drdavidpalma & our team!

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Sondos Zayed Reposted

This is a bit different #radonc; Lu-177 Dotatate for refractory, high risk treated méningiome WHO 2-3. N=20, demonstrating efficacy. G3 lymphopenia in 50%, anaemia in 5% #ASTR024

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Sondos Zayed Reposted

☢️Neoadjuvant CRT vs. ChT for initially unresectable locally advanced "Colon" cancer @eClinicalMed ➡️45 patients ✅R0 resection: 80% vs. 20%, P < 0.001 ✅3-year PFS: 76% vs. 45% , P = 0.049 ✅3-year OS: 87.6% vs. 75% , P = 0.037 ✅No differences in severe AEs ❗️Study was…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Sondos Zayed Reposted

Some trial caveats (small N, no MMR status, chemo could be longer than XELOX x 4)… But this RCT is a good reminder that for rare case of unresectable colon cancer, chemoRT should be considered for downstaging to facilitate R0 resection. It is even in 2024 NCCN guidelines 🙏!

Tweet Image 1

☢️Neoadjuvant CRT vs. ChT for initially unresectable locally advanced "Colon" cancer @eClinicalMed ➡️45 patients ✅R0 resection: 80% vs. 20%, P < 0.001 ✅3-year PFS: 76% vs. 45% , P = 0.049 ✅3-year OS: 87.6% vs. 75% , P = 0.037 ✅No differences in severe AEs ❗️Study was…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4


Loading...

Something went wrong.


Something went wrong.